首页ARCT • NASDAQ
add
Arcturus Therapeutics Holdings Inc
昨日收盘价
$11.91
当日价格范围
$12.05 - $12.93
年度波幅
$8.04 - $42.42
市值
3.47亿 USD
平均交易量
44.54万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
收入 | 2938.20万 | -22.70% |
经营支出 | 1131.50万 | -23.81% |
净收入 | -1407.60万 | 47.51% |
净利润率 | -47.91 | 32.09% |
每股收益 | -0.52 | 48.00% |
息税折旧摊销前利润 | -1602.50万 | 45.69% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.17亿 | -24.77% |
总资产 | 3.32亿 | -20.79% |
负债总额 | 9802.60万 | -36.71% |
权益总额 | 2.34亿 | — |
发行在外的股份 | 2712.06万 | — |
市净率 | 1.38 | — |
资产回报率 | -12.45% | — |
资本回报率 | -15.41% | — |
现金流
现金净变动
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
净收入 | -1407.60万 | 47.51% |
来自运营的现金 | -3513.80万 | -532.32% |
投资现金 | -13.70万 | 42.92% |
融资现金 | 1519.50万 | 594.47% |
现金净变动 | -2008.00万 | -456.39% |
自由现金流 | -1228.42万 | -137.89% |
简介
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA.
The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. As of 2021, vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025. Wikipedia
CEO
成立时间
2013
员工数量
175
